Evidence map›Paper›PMID 27550353›Full record

ArticleAntimicrobial agents and chemotherapy2016

Sequence Type 48 Escherichia coli Carrying the blaCTX-M-1 IncI1/ST3 Plasmid in Drinking Water in France.

Jean-Yves Madec, Marisa Haenni, Cécile Ponsin, Nicolas Kieffer, Emmanuelle Rion, Benoit Gassilloud

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Extended Spectrum β-Lactamase (ESBL) ProducingAntibiotics (Basel, Switzerland) · 2020
    Review
  10. Observational
  11. Antibiotic-ResistantThe American journal of tropical medicine and hygiene · 2019
    Article
  12. Article
  13. Review
  14. ESBL-producingFood safety (Tokyo, Japan) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes, ANSES Site de Lyon, Lyon, France.
Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, ANSES Site de Lyon, Lyon, France marisa.haenni@anses.fr.
Cécile PonsinUnité Antibiorésistance et Virulence Bactériennes, ANSES Site de Lyon, Lyon, France.
Nicolas KiefferUnité Antibiorésistance et Virulence Bactériennes, ANSES Site de Lyon, Lyon, France.
Emmanuelle RionUnité de Microbiologie des Eaux, Laboratoire d'Hydrologie de Nancy, ANSES Site de Nancy, Nancy, France.
Benoit GassilloudUnité de Microbiologie des Eaux, Laboratoire d'Hydrologie de Nancy, ANSES Site de Nancy, Nancy, France.
Laboratoire de Chimie Physique et Microbiologie pour l'Environnement · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drinking water has rarely been recognized as a source of antimicrobial resistance for humans, and only in low-income countries. Here, a sequence type 48 Escherichia coli isolate carrying the blaCTX-M-1 IncI1/ST3 plasmid was recovered from drinking water in France. This plasmid was similar to other blaCTX-M-1 IncI1/ST3 plasmids found previously in animals and humans. Our findings highlight the possible human transfer of extended-spectrum β-lactamase (ESBL) genes through drinking water in high-income countries.

Indexed as

beta-LactamasesDrinking WaterEscherichia coliFrancePlasmidsbeta-Lactamasesbeta-lactamase TEM-3Drinking Water

Identifiers

PMID27550353
PMCPMC5038290
OpenAlexW2530493375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.